<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34476545</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1420-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>19-20</Issue><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Cellular and molecular life sciences : CMLS</Title><ISOAbbreviation>Cell Mol Life Sci</ISOAbbreviation></Journal><ArticleTitle>Sex-dependent effects of amyloid precursor-like protein 2 in the SOD1-G37R transgenic mouse model of MND.</ArticleTitle><Pagination><StartPage>6605</StartPage><EndPage>6630</EndPage><MedlinePgn>6605-6630</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00018-021-03924-5</ELocationID><Abstract><AbstractText>Motor neurone disease (MND) is a neurodegenerative disorder characterised by progressive destruction of motor neurons, muscle paralysis and death. The amyloid precursor protein (APP) is highly expressed in the central nervous system and has been shown to modulate disease outcomes in MND. APP is part of a gene family that includes the amyloid precursor-like protein 1 (APLP1) and 2 (APLP2) genes. In the present study, we investigated the role of APLP2 in MND through the examination of human spinal cord tissue and by crossing APLP2 knockout mice with the superoxide dismutase 1 (SOD1-G37R) transgenic mouse model of MND. We found the expression of APLP2 is elevated in the spinal cord from human cases of MND and that this feature of the human disease is reproduced in SOD1-G37R mice at the End-stage of their MND-like phenotype progression. APLP2 deletion in SOD1-G37R mice significantly delayed disease progression and increased the survival of female SOD1-G37R mice. Molecular and biochemical analysis showed female SOD1-G37R:APLP2-/- mice displayed improved innervation of the neuromuscular junction, ameliorated atrophy of muscle fibres with increased APP protein expression levels in the gastrocnemius muscle. These results indicate a sex-dependent role for APLP2 in mutant SOD1-mediated MND and further support the APP family as a potential target for further investigation into the cause and regulation of MND.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Truong</LastName><ForeName>Phan H</ForeName><Initials>PH</Initials><Identifier Source="ORCID">0000-0002-9964-0678</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville, VIC, 3010, Australia. phan.truong@florey.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oxidation Biology Unit, The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, VIC, 3010, Australia. phan.truong@florey.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crouch</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville, VIC, 3010, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hilton</LastName><ForeName>James B W</ForeName><Initials>JBW</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville, VIC, 3010, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLean</LastName><ForeName>Catriona A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Anatomical Pathology, Alfred Hospital, Melbourne, VIC, 3005, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cappai</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville, VIC, 3010, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciccotosto</LastName><ForeName>Giuseppe D</ForeName><Initials>GD</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville, VIC, 3010, Australia. j.ciccotosto@unimelb.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Jenny Barr Smith Research Grants</GrantID><Agency>Motor Neurone Disease Research Institute of Australia</Agency><Country/></Grant><Grant><GrantID>Betty Laidlaw</GrantID><Agency>Motor Neurone Disease Research Institute of Australia</Agency><Country/></Grant><Grant><GrantID>Beryl Bayley</GrantID><Agency>Motor Neurone Disease Research Institute of Australia</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cell Mol Life Sci</MedlineTA><NlmUniqueID>9705402</NlmUniqueID><ISSNLinking>1420-682X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C492952">Aplp2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002490" MajorTopicYN="N">Central Nervous System</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="N">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018485" MajorTopicYN="N">Muscle Fibers, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyloid precursor protein</Keyword><Keyword MajorTopicYN="N">Amyloid precursor-like protein</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword><Keyword MajorTopicYN="N">SOD1-G37R</Keyword><Keyword MajorTopicYN="N">Sex differences</Keyword></KeywordList><CoiStatement>We have no conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>3</Day><Hour>7</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34476545</ArticleId><ArticleId IdType="pmc">PMC8558206</ArticleId><ArticleId IdType="doi">10.1007/s00018-021-03924-5</ArticleId><ArticleId IdType="pii">10.1007/s00018-021-03924-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dharmadasa T, Henderson RD, Talman PS, Macdonell RA, Mathers S, Schultz DW, et al. Motor neurone disease: progress and challenges. Med J Aust. 2017;206(8):357&#x2013;362. doi: 10.5694/mja16.01063.</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/mja16.01063</ArticleId><ArticleId IdType="pubmed">28446118</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HP, Van Broeckhoven C, van der Zee J. ALS genes in the genomic era and their implications for FTD. Trends Genet. 2018;34(6):404&#x2013;423. doi: 10.1016/j.tig.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Rouleau GA, Ravits J, Cashman NR. Clinical spectrum of amyotrophic lateral sclerosis (ALS) Cold Spring Harb Perspect Med. 2017;7(8):a024117. doi: 10.1101/cshperspect.a024117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024117</ArticleId><ArticleId IdType="pmc">PMC5538408</ArticleId><ArticleId IdType="pubmed">28003278</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gend Med. 2010;7(6):557&#x2013;570. doi: 10.1016/j.genm.2010.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genm.2010.11.010</ArticleId><ArticleId IdType="pubmed">21195356</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjaly ZR, Scott KM, Abhinav K, Wijesekera L, Ganesalingam J, Goldstein LH, et al. The sex ratio in amyotrophic lateral sclerosis: a population based study. Amyotroph Lateral Scler. 2010;11(5):439&#x2013;442. doi: 10.3109/17482961003610853.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482961003610853</ArticleId><ArticleId IdType="pmc">PMC6485484</ArticleId><ArticleId IdType="pubmed">20225930</ArticleId></ArticleIdList></Reference><Reference><Citation>Li TM, Alberman E, Swash M. Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease. J Neurol Neurosurg Psychiatry. 1988;51(6):778&#x2013;784. doi: 10.1136/jnnp.51.6.778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.51.6.778</ArticleId><ArticleId IdType="pmc">PMC1033147</ArticleId><ArticleId IdType="pubmed">3404186</ArticleId></ArticleIdList></Reference><Reference><Citation>Shashiraj AA. Juvenile amyotrophic lateral sclerosis. Indian J Pediatr. 2006;73(3):225&#x2013;226. doi: 10.1007/BF02825486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02825486</ArticleId><ArticleId IdType="pubmed">16567917</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, et al. Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2008;79(1):33&#x2013;37. doi: 10.1136/jnnp.2007.118018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2007.118018</ArticleId><ArticleId IdType="pubmed">17550991</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Guennoc AM, Veyrat-Durebex C, Gordon PH, Andres CR, Camu W, et al. Amyotrophic lateral sclerosis: a hormonal condition? Amyotroph Lateral Scler. 2012;13(6):585&#x2013;588. doi: 10.3109/17482968.2012.706303.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.706303</ArticleId><ArticleId IdType="pubmed">22873563</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvin M, Gaffney R, Corr B, Mays I, Hardiman O. From first symptoms to diagnosis of amyotrophic lateral sclerosis: perspectives of an Irish informal caregiver cohort-a thematic analysis. BMJ Open. 2017;7(3):e014985. doi: 10.1136/bmjopen-2016-014985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-014985</ArticleId><ArticleId IdType="pmc">PMC5372020</ArticleId><ArticleId IdType="pubmed">28320799</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R, et al. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology. 2009;72(8):725&#x2013;731. doi: 10.1212/01.wnl.0000343008.26874.d1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000343008.26874.d1</ArticleId><ArticleId IdType="pubmed">19237701</ArticleId></ArticleIdList></Reference><Reference><Citation>Deliz B, Ramos K, Perez CM. Characterization of patients with amyotrophic lateral sclerosis attending the muscular dystrophy association-supported clinics in Puerto Rico. P R Health Sci J. 2018;37(1):5&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">29547678</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Bosch L. Genetic rodent models of amyotrophic lateral sclerosis. J Biomed Biotechnol. 2011;2011:348765. doi: 10.1155/2011/290874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/290874</ArticleId><ArticleId IdType="pmc">PMC3022221</ArticleId><ArticleId IdType="pubmed">21274268</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander GM, Erwin KL, Byers N, Deitch JS, Augelli BJ, Blankenhorn EP, et al. Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS. Brain Res Mol Brain Res. 2004;130(1&#x2013;2):7&#x2013;15. doi: 10.1016/j.molbrainres.2004.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molbrainres.2004.07.002</ArticleId><ArticleId IdType="pubmed">15519671</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi CI, Lee YD, Gwag BJ, Cho SI, Kim SS, Suh-Kim H. Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice. J Neurol Sci. 2008;268(1&#x2013;2):40&#x2013;47. doi: 10.1016/j.jns.2007.10.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2007.10.024</ArticleId><ArticleId IdType="pubmed">18054961</ArticleId></ArticleIdList></Reference><Reference><Citation>Miana-Mena FJ, Munoz MJ, Yague G, Mendez M, Moreno M, Ciriza J, et al. Optimal methods to characterize the G93A mouse model of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005;6(1):55&#x2013;62. doi: 10.1080/14660820510026162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820510026162</ArticleId><ArticleId IdType="pubmed">16036427</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould TW, Buss RR, Vinsant S, Prevette D, Sun W, Knudson CM, et al. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J Neurosci. 2006;26(34):8774&#x2013;8786. doi: 10.1523/JNEUROSCI.2315-06.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2315-06.2006</ArticleId><ArticleId IdType="pmc">PMC6674380</ArticleId><ArticleId IdType="pubmed">16928866</ArticleId></ArticleIdList></Reference><Reference><Citation>Kieran D, Woods I, Villunger A, Strasser A, Prehn JH. Deletion of the BH3-only protein puma protects motoneurons from ER stress-induced apoptosis and delays motoneuron loss in ALS mice. Proc Natl Acad Sci USA. 2007;104(51):20606&#x2013;20611. doi: 10.1073/pnas.0707906105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0707906105</ArticleId><ArticleId IdType="pmc">PMC2154478</ArticleId><ArticleId IdType="pubmed">18077368</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker P, Hawlik A, Lehnert S, Jahn O, Meier S, Gorz E, et al. Neuroprotective function of cellular prion protein in a mouse model of amyotrophic lateral sclerosis. Am J Pathol. 2010;176(3):1409&#x2013;1420. doi: 10.2353/ajpath.2010.090355.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2010.090355</ArticleId><ArticleId IdType="pmc">PMC2832160</ArticleId><ArticleId IdType="pubmed">20075202</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryson JB, Hobbs C, Parsons MJ, Bosch KD, Pandraud A, Walsh FS, et al. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Hum Mol Genet. 2012;21(17):3871&#x2013;3882. doi: 10.1093/hmg/dds215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds215</ArticleId><ArticleId IdType="pubmed">22678056</ArticleId></ArticleIdList></Reference><Reference><Citation>Plummer S, Van den Heuvel C, Thornton E, Corrigan F, Cappai R. The neuroprotective properties of the amyloid precursor protein following traumatic brain injury. Aging Dis. 2016;7(2):163&#x2013;179. doi: 10.14336/AD.2015.0907.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2015.0907</ArticleId><ArticleId IdType="pmc">PMC4809608</ArticleId><ArticleId IdType="pubmed">27114849</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie YY, Yao ZB, Wu WT. Survival of motor neurons and expression of beta-amyloid protein in the aged rat spinal cord. NeuroReport. 2000;11(4):697&#x2013;700. doi: 10.1097/00001756-200003200-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-200003200-00009</ArticleId><ArticleId IdType="pubmed">10757503</ArticleId></ArticleIdList></Reference><Reference><Citation>Itoh T, Satou T, Nishida S, Tsubaki M, Hashimoto S, Ito H. Expression of amyloid precursor protein after rat traumatic brain injury. Neurol Res. 2009;31(1):103&#x2013;109. doi: 10.1179/016164108X323771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/016164108X323771</ArticleId><ArticleId IdType="pubmed">19228461</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Iwata M. Immunoreactivity of beta-amyloid precursor protein in amyotrophic lateral sclerosis. Acta Neuropathol. 1999;97(5):463&#x2013;468. doi: 10.1007/s004010051015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010051015</ArticleId><ArticleId IdType="pubmed">10334483</ArticleId></ArticleIdList></Reference><Reference><Citation>Koistinen H, Prinjha R, Soden P, Harper A, Banner SJ, Pradat PF, et al. Elevated levels of amyloid precursor protein in muscle of patients with amyotrophic lateral sclerosis and a mouse model of the disease. Muscle Nerve. 2006;34(4):444&#x2013;450. doi: 10.1002/mus.20612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20612</ArticleId><ArticleId IdType="pubmed">16856153</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovich-Toidman P, Rabinovich-Nikitin I, Ezra A, Barbiro B, Fogel H, Slutsky I, et al. Mutant SOD1 increases APP expression and phosphorylation in cellular and animal models of ALS. PLoS ONE. 2015;10(11):e0143420. doi: 10.1371/journal.pone.0143420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0143420</ArticleId><ArticleId IdType="pmc">PMC4658003</ArticleId><ArticleId IdType="pubmed">26600047</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker P, Hendrich C, Sperfeld AD, Jesse S, Lehnert S, Pabst A, et al. Concentrations of beta-amyloid precursor protein processing products in cerebrospinal fluid of patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration. J Neural Transm (Vienna) 2009;116(9):1169&#x2013;1178. doi: 10.1007/s00702-009-0271-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-009-0271-4</ArticleId><ArticleId IdType="pubmed">19649690</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, Yang G, Mosier DR, Chang P, Zaidi T, Gong YD, et al. Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-Like protein 2. J Neurosci. 2005;25(5):1219&#x2013;1225. doi: 10.1523/JNEUROSCI.4660-04.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4660-04.2005</ArticleId><ArticleId IdType="pmc">PMC6725967</ArticleId><ArticleId IdType="pubmed">15689559</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappai R, Mok SS, Galatis D, Tucker DF, Henry A, Beyreuther K, et al. Recombinant human amyloid precursor-like protein 2 (APLP2) expressed in the yeast Pichia pastoris can stimulate neurite outgrowth. FEBS Lett. 1999;442(1):95&#x2013;98. doi: 10.1016/S0014-5793(98)01635-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(98)01635-4</ArticleId><ArticleId IdType="pubmed">9923612</ArticleId></ArticleIdList></Reference><Reference><Citation>Truong PH, Ciccotosto GD, Merson TD, Spoerri L, Chuei MJ, Ayers M, et al. Amyloid precursor protein and amyloid precursor-like protein 2 have distinct roles in modulating myelination, demyelination, and remyelination of axons. Glia. 2019;67(3):525&#x2013;538. doi: 10.1002/glia.23561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23561</ArticleId><ArticleId IdType="pubmed">30506868</ArticleId></ArticleIdList></Reference><Reference><Citation>Herms J, Anliker B, Heber S, Ring S, Fuhrmann M, Kretzschmar H, et al. Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members. EMBO J. 2004;23(20):4106&#x2013;4115. doi: 10.1038/sj.emboj.7600390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7600390</ArticleId><ArticleId IdType="pmc">PMC524337</ArticleId><ArticleId IdType="pubmed">15385965</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmans BA, Shariati SA, Habets RL, Verstreken P, Schoonjans L, Muller U, et al. Neurons generated from APP/APLP1/APLP2 triple knockout embryonic stem cells behave normally in vitro and in vivo: lack of evidence for a cell autonomous role of the amyloid precursor protein in neuronal differentiation. Stem Cells. 2010;28(3):399&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">20049903</ArticleId></ArticleIdList></Reference><Reference><Citation>Shariati SA, Lau P, Hassan BA, Muller U, Dotti CG, De Strooper B, et al. APLP2 regulates neuronal stem cell differentiation during cortical development. J Cell Sci. 2013;126(Pt 5):1268&#x2013;1277.</Citation><ArticleIdList><ArticleId IdType="pubmed">23345401</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham BE, Wlodek ME, Ciccotosto GD, Fam BC, Masters CL, Proietto J, et al. Identification of the Alzheimer&#x2019;s disease amyloid precursor protein (APP) and its homologue APLP2 as essential modulators of glucose and insulin homeostasis and growth. J Pathol. 2008;215(2):155&#x2013;163. doi: 10.1002/path.2343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2343</ArticleId><ArticleId IdType="pubmed">18393365</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham BE, Ciccotosto GD, Cappai R. Combined deletions of amyloid precursor protein and amyloid precursor-like protein 2 reveal different effects on mouse brain metal homeostasis. Metallomics. 2014;6(3):598&#x2013;603. doi: 10.1039/c3mt00358b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c3mt00358b</ArticleId><ArticleId IdType="pubmed">24448592</ArticleId></ArticleIdList></Reference><Reference><Citation>White AR, Reyes R, Mercer JF, Camakaris J, Zheng H, Bush AI, et al. Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Res. 1999;842(2):439&#x2013;444. doi: 10.1016/S0006-8993(99)01861-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(99)01861-2</ArticleId><ArticleId IdType="pubmed">10526140</ArticleId></ArticleIdList></Reference><Reference><Citation>Tkatchenko AV, Tkatchenko TV, Guggenheim JA, Verhoeven VJ, Hysi PG, Wojciechowski R, et al. APLP2 regulates refractive error and myopia development in mice and humans. PLoS Genet. 2015;11(8):e1005432. doi: 10.1371/journal.pgen.1005432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1005432</ArticleId><ArticleId IdType="pmc">PMC4551475</ArticleId><ArticleId IdType="pubmed">26313004</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinet V, An N, Ciccotosto GD, Bruban J, Maoui A, Bellingham SA, et al. APP involvement in retinogenesis of mice. Acta Neuropathol. 2011;121(3):351&#x2013;363. doi: 10.1007/s00401-010-0762-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0762-2</ArticleId><ArticleId IdType="pubmed">20978902</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinet V, Ciccotosto GD, Delaunay K, Borras C, Ranchon-Cole I, Kostic C, et al. Amyloid precursor-like protein 2 deletion-induced retinal synaptopathy related to congenital stationary night blindness: structural, functional and molecular characteristics. Mol Brain. 2016;9(1):64. doi: 10.1186/s13041-016-0245-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-016-0245-z</ArticleId><ArticleId IdType="pmc">PMC4897877</ArticleId><ArticleId IdType="pubmed">27267879</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilton JB, Kysenius K, White AR, Crouch PJ. The accumulation of enzymatically inactive cuproenzymes is a CNS-specific phenomenon of the SOD1(G37R) mouse model of ALS and can be restored by overexpressing the human copper transporter hCTR1. Exp Neurol. 2018;307:118&#x2013;128. doi: 10.1016/j.expneurol.2018.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2018.06.006</ArticleId><ArticleId IdType="pubmed">29906423</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 1995;14(6):1105&#x2013;1116. doi: 10.1016/0896-6273(95)90259-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(95)90259-7</ArticleId><ArticleId IdType="pubmed">7605627</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC, Bendotti C, Blaugrund E, Chio A, Greensmith L, Loeffler JP, et al. Guidelines for preclinical animal research in ALS/MND: a consensus meeting. Amyotroph Lateral Scler. 2010;11(1&#x2013;2):38&#x2013;45. doi: 10.3109/17482960903545334.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960903545334</ArticleId><ArticleId IdType="pubmed">20184514</ArticleId></ArticleIdList></Reference><Reference><Citation>Luu L, Ciccotosto GD, Vella LJ, Cheng L, Roisman LC, Multhaup G, et al. Amyloid precursor protein dimerisation reduces neurite outgrowth. Mol Neurobiol. 2019;56(1):13&#x2013;28. doi: 10.1007/s12035-018-1070-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1070-4</ArticleId><ArticleId IdType="pubmed">29675574</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasco W, Gurubhagavatula S, Paradis MD, Romano DM, Sisodia SS, Hyman BT, et al. Isolation and characterization of APLP2 encoding a homologue of the Alzheimer&#x2019;s associated amyloid beta protein precursor. Nat Genet. 1993;5(1):95&#x2013;100. doi: 10.1038/ng0993-95.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0993-95</ArticleId><ArticleId IdType="pubmed">8220435</ArticleId></ArticleIdList></Reference><Reference><Citation>White AR, Zheng H, Galatis D, Maher F, Hesse L, Multhaup G, et al. Survival of cultured neurons from amyloid precursor protein knock-out mice against Alzheimer&#x2019;s amyloid-beta toxicity and oxidative stress. J Neurosci. 1998;18(16):6207&#x2013;6217. doi: 10.1523/JNEUROSCI.18-16-06207.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.18-16-06207.1998</ArticleId><ArticleId IdType="pmc">PMC6793217</ArticleId><ArticleId IdType="pubmed">9698314</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamalainen N, Pette D. The histochemical profiles of fast fiber types IIB, IID, and IIA in skeletal muscles of mouse, rat, and rabbit. J Histochem Cytochem. 1993;41(5):733&#x2013;743. doi: 10.1177/41.5.8468455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/41.5.8468455</ArticleId><ArticleId IdType="pubmed">8468455</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitner M, Menzies S, Lutz C. Working with ALS mice: guidelines for preclinical testing and colony management. The Jackson Laboratory; 2009.</Citation></Reference><Reference><Citation>Zhou C, Zhang C, Zhao R, Chi S, Ge P, Zhang C. Human marrow stromal cells reduce microglial activation to protect motor neurons in a transgenic mouse model of amyotrophic lateral sclerosis. J Neuroinflammation. 2013;10:52. doi: 10.1186/1742-2094-10-52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-10-52</ArticleId><ArticleId IdType="pmc">PMC3651332</ArticleId><ArticleId IdType="pubmed">23631660</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall ED, Oostveen JA, Gurney ME. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia. 1998;23(3):249&#x2013;256. doi: 10.1002/(SICI)1098-1136(199807)23:3&lt;249::AID-GLIA7&gt;3.0.CO;2-#.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1098-1136(199807)23:3&lt;249::AID-GLIA7&gt;3.0.CO;2-#</ArticleId><ArticleId IdType="pubmed">9633809</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushner PD, Stephenson DT, Wright S. Reactive astrogliosis is widespread in the subcortical white matter of amyotrophic lateral sclerosis brain. J Neuropathol Exp Neurol. 1991;50(3):263&#x2013;277. doi: 10.1097/00005072-199105000-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199105000-00008</ArticleId><ArticleId IdType="pubmed">2022968</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawkins E, Small DH. Insights into the physiological function of the beta-amyloid precursor protein: beyond Alzheimer&#x2019;s disease. J Neurochem. 2014;129(5):756&#x2013;769. doi: 10.1111/jnc.12675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12675</ArticleId><ArticleId IdType="pmc">PMC4314671</ArticleId><ArticleId IdType="pubmed">24517464</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller UC, Deller T, Korte M. Not just amyloid: physiological functions of the amyloid precursor protein family. Nat Rev Neurosci. 2017;18(5):281. doi: 10.1038/nrn.2017.29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2017.29</ArticleId><ArticleId IdType="pubmed">28360418</ArticleId></ArticleIdList></Reference><Reference><Citation>Akaaboune M, Allinquant B, Farza H, Roy K, Magoul R, Fiszman M, et al. Developmental regulation of amyloid precursor protein at the neuromuscular junction in mouse skeletal muscle. Mol Cell Neurosci. 2000;15(4):355&#x2013;367. doi: 10.1006/mcne.2000.0834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mcne.2000.0834</ArticleId><ArticleId IdType="pubmed">10845772</ArticleId></ArticleIdList></Reference><Reference><Citation>Klevanski M, Saar M, Baumkotter F, Weyer SW, Kins S, Muller UC. Differential role of APP and APLPs for neuromuscular synaptic morphology and function. Mol Cell Neurosci. 2014;61:201&#x2013;210. doi: 10.1016/j.mcn.2014.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2014.06.004</ArticleId><ArticleId IdType="pubmed">24998676</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang G, Gong YD, Gong K, Jiang WL, Kwon E, Wang P, et al. Reduced synaptic vesicle density and active zone size in mice lacking amyloid precursor protein (APP) and APP-like protein 2. Neurosci Lett. 2005;384(1&#x2013;2):66&#x2013;71. doi: 10.1016/j.neulet.2005.04.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2005.04.040</ArticleId><ArticleId IdType="pubmed">15919150</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci. 2000;20(7):2534&#x2013;2542. doi: 10.1523/JNEUROSCI.20-07-02534.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-07-02534.2000</ArticleId><ArticleId IdType="pmc">PMC6772256</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun S, Santos AF, Saxena S, Xu L, Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci. 2006;9(3):408&#x2013;419. doi: 10.1038/nn1653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1653</ArticleId><ArticleId IdType="pubmed">16474388</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinsant S, Mansfield C, Jimenez-Moreno R, Del Gaizo MV, Yoshikawa M, Hampton TG, et al. Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part II, results and discussion. Brain Behav. 2013;3(4):431&#x2013;457. doi: 10.1002/brb3.142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.142</ArticleId><ArticleId IdType="pmc">PMC3869683</ArticleId><ArticleId IdType="pubmed">24381813</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman AM, Khandelwal PJ, Rebeck GW, Moussa CE. Wild type TDP-43 induces neuro-inflammation and alters APP metabolism in lentiviral gene transfer models. Exp Neurol. 2012;235(1):297&#x2013;305. doi: 10.1016/j.expneurol.2012.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2012.02.011</ArticleId><ArticleId IdType="pmc">PMC3434705</ArticleId><ArticleId IdType="pubmed">22402344</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilton JB, White AR, Crouch PJ. Endogenous Cu in the central nervous system fails to satiate the elevated requirement for Cu in a mutant SOD1 mouse model of ALS. Metallomics. 2016;8(9):1002&#x2013;1011. doi: 10.1039/C6MT00099A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C6MT00099A</ArticleId><ArticleId IdType="pubmed">27357743</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos-Galindo M, Acaz-Fonseca E, Bellini MJ, Garcia-Segura LM. Sex differences in the inflammatory response of primary astrocytes to lipopolysaccharide. Biol Sex Differ. 2011;2:7. doi: 10.1186/2042-6410-2-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2042-6410-2-7</ArticleId><ArticleId IdType="pmc">PMC3143074</ArticleId><ArticleId IdType="pubmed">21745355</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Hurn PD, Roselli CE, Alkayed NJ. Role of P450 aromatase in sex-specific astrocytic cell death. J Cereb Blood Flow Metab. 2007;27(1):135&#x2013;141. doi: 10.1038/sj.jcbfm.9600331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.jcbfm.9600331</ArticleId><ArticleId IdType="pubmed">16736049</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Segura LM, Melcangi RC. Steroids and glial cell function. Glia. 2006;54(6):485&#x2013;498. doi: 10.1002/glia.20404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20404</ArticleId><ArticleId IdType="pubmed">16906540</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentleman SM, Nash MJ, Sweeting CJ, Graham DI, Roberts GW. Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci Lett. 1993;160(2):139&#x2013;144. doi: 10.1016/0304-3940(93)90398-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(93)90398-5</ArticleId><ArticleId IdType="pubmed">8247344</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce JE, Trojanowski JQ, Graham DI, Smith DH, McIntosh TK. Immunohistochemical characterization of alterations in the distribution of amyloid precursor proteins and beta-amyloid peptide after experimental brain injury in the rat. J Neurosci. 1996;16(3):1083&#x2013;1090. doi: 10.1523/JNEUROSCI.16-03-01083.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.16-03-01083.1996</ArticleId><ArticleId IdType="pmc">PMC6578806</ArticleId><ArticleId IdType="pubmed">8558237</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Heuvel C, Blumbergs PC, Finnie JW, Manavis J, Jones NR, Reilly PL, et al. Upregulation of amyloid precursor protein messenger RNA in response to traumatic brain injury: an ovine head impact model. Exp Neurol. 1999;159(2):441&#x2013;450. doi: 10.1006/exnr.1999.7150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.1999.7150</ArticleId><ArticleId IdType="pubmed">10506515</ArticleId></ArticleIdList></Reference><Reference><Citation>Thornton E, Vink R, Blumbergs PC, Van Den Heuvel C. Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats. Brain Res. 2006;1094(1):38&#x2013;46. doi: 10.1016/j.brainres.2006.03.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2006.03.107</ArticleId><ArticleId IdType="pubmed">16697978</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrigan F, Vink R, Blumbergs PC, Masters CL, Cappai R, van den Heuvel C. Characterisation of the effect of knockout of the amyloid precursor protein on outcome following mild traumatic brain injury. Brain Res. 2012;1451:87&#x2013;99. doi: 10.1016/j.brainres.2012.02.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.02.045</ArticleId><ArticleId IdType="pubmed">22424792</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrigan F, Vink R, Blumbergs PC, Masters CL, Cappai R, van den Heuvel C. sAPPalpha rescues deficits in amyloid precursor protein knockout mice following focal traumatic brain injury. J Neurochem. 2012;122(1):208&#x2013;220. doi: 10.1111/j.1471-4159.2012.07761.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2012.07761.x</ArticleId><ArticleId IdType="pubmed">22519988</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrigan F, Thornton E, Roisman LC, Leonard AV, Vink R, Blumbergs PC, et al. The neuroprotective activity of the amyloid precursor protein against traumatic brain injury is mediated via the heparin binding site in residues 96&#x2013;110. J Neurochem. 2014;128(1):196&#x2013;204. doi: 10.1111/jnc.12391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12391</ArticleId><ArticleId IdType="pubmed">23919582</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J, Thinakaran G, Guo Y, Sisodia SS, Yu FX. A role for amyloid precursor-like protein 2 in corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 1998;39(2):292&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">9477985</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters HL, Tuli A, Wang X, Liu C, Pan Z, Ouellette MM, et al. Relevance of amyloid precursor-like protein 2 C-terminal fragments in pancreatic cancer cells. Int J Oncol. 2012;41(4):1464&#x2013;1474. doi: 10.3892/ijo.2012.1553.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2012.1553</ArticleId><ArticleId IdType="pmc">PMC3482291</ArticleId><ArticleId IdType="pubmed">22797723</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters OM, Ghasemi M, Brown RH., Jr Emerging mechanisms of molecular pathology in ALS. J Clin Invest. 2015;125(5):1767&#x2013;1779. doi: 10.1172/JCI71601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI71601</ArticleId><ArticleId IdType="pmc">PMC4463186</ArticleId><ArticleId IdType="pubmed">25932674</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss AC, Doran PP, Macmathuna P. in silico promoter analysis can predict genes of functional relevance in cell proliferation: validation in a colon cancer model. Transl Oncogenomics. 2007;2:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3634709</ArticleId><ArticleId IdType="pubmed">23641142</ArticleId></ArticleIdList></Reference><Reference><Citation>Abba MC, Drake JA, Hawkins KA, Hu Y, Sun H, Notcovich C, et al. Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression. Breast Cancer Res. 2004;6(5):R499&#x2013;513. doi: 10.1186/bcr899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/bcr899</ArticleId><ArticleId IdType="pmc">PMC549167</ArticleId><ArticleId IdType="pubmed">15318932</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters HL, Yan Y, Nordgren TM, Cutucache CE, Joshi SS, Solheim JC. Amyloid precursor-like protein 2 suppresses irradiation-induced apoptosis in Ewing sarcoma cells and is elevated in immune-evasive Ewing sarcoma cells. Cancer Biol Ther. 2013;14(8):752&#x2013;760. doi: 10.4161/cbt.25183.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cbt.25183</ArticleId><ArticleId IdType="pmc">PMC3841215</ArticleId><ArticleId IdType="pubmed">23792571</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters HL, Yan Y, Solheim JC. APLP2 regulates the expression of MHC class I molecules on irradiated Ewing&#x2019;s sarcoma cells. Oncoimmunology. 2013;2(10):e26293. doi: 10.4161/onci.26293.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/onci.26293</ArticleId><ArticleId IdType="pmc">PMC3862638</ArticleId><ArticleId IdType="pubmed">24353913</ArticleId></ArticleIdList></Reference><Reference><Citation>Heber S, Herms J, Gajic V, Hainfellner J, Aguzzi A, Rulicke T, et al. Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J Neurosci. 2000;20(21):7951&#x2013;7963. doi: 10.1523/JNEUROSCI.20-21-07951.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-21-07951.2000</ArticleId><ArticleId IdType="pmc">PMC6772747</ArticleId><ArticleId IdType="pubmed">11050115</ArticleId></ArticleIdList></Reference><Reference><Citation>Gajowiak A, Stys A, Starzynski RR, Bednarz A, Lenartowicz M, Staron R, et al. Mice overexpressing both non-mutated human SOD1 and mutated SOD1(G93A) genes: a competent experimental model for studying iron metabolism in amyotrophic lateral sclerosis. Front Mol Neurosci. 2015;8(82):82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4701970</ArticleId><ArticleId IdType="pubmed">26778957</ArticleId></ArticleIdList></Reference><Reference><Citation>Truong PH, Ciccotosto GD, Cappai R. Analysis of motor function in amyloid precursor-like protein 2 knockout mice: the effects of ageing and sex. Neurochem Res. 2019;44(6):1356&#x2013;1366. doi: 10.1007/s11064-018-2669-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-018-2669-6</ArticleId><ArticleId IdType="pubmed">30362021</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo ST, Steyn FJ, McCombe PA. Gender differences in autoimmune disease. Front Neuroendocrinol. 2014;35(3):347&#x2013;369. doi: 10.1016/j.yfrne.2014.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yfrne.2014.04.004</ArticleId><ArticleId IdType="pubmed">24793874</ArticleId></ArticleIdList></Reference><Reference><Citation>Regitz-Zagrosek V, Kararigas G. Mechanistic pathways of sex differences in cardiovascular disease. Physiol Rev. 2017;97(1):1&#x2013;37. doi: 10.1152/physrev.00021.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00021.2015</ArticleId><ArticleId IdType="pubmed">27807199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HI, Lim H, Moon A. Sex differences in cancer: epidemiology, genetics and therapy. Biomol Ther (Seoul) 2018;26(4):335&#x2013;342. doi: 10.4062/biomolther.2018.103.</Citation><ArticleIdList><ArticleId IdType="doi">10.4062/biomolther.2018.103</ArticleId><ArticleId IdType="pmc">PMC6029678</ArticleId><ArticleId IdType="pubmed">29949843</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinares-Garcia P, Stratikopoulos M, Zagato A, Loke H, Lee J. Sex: a significant risk factor for neurodevelopmental and neurodegenerative disorders. Brain Sci. 2018;8(8):154. doi: 10.3390/brainsci8080154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci8080154</ArticleId><ArticleId IdType="pmc">PMC6120011</ArticleId><ArticleId IdType="pubmed">30104506</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontana A, Marin B, Luna J, Beghi E, Logroscino G, Boum&#xe9;diene F, et al. Time-trend evolution and determinants of sex ratio in amyotrophic lateral sclerosis: a dose-response meta-analysis. J Neurol. 2021;268:2973&#x2013;2984. doi: 10.1007/s00415-021-10464-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10464-2</ArticleId><ArticleId IdType="pubmed">33630135</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiman-Patterson TD, Deitch JS, Blankenhorn EP, Erwin KL, Perreault MJ, Alexander BK, et al. Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS. J Neurol Sci. 2005;236(1&#x2013;2):1&#x2013;7. doi: 10.1016/j.jns.2005.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2005.02.006</ArticleId><ArticleId IdType="pubmed">16024047</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiman-Patterson TD, Sher RB, Blankenhorn EA, Alexander G, Deitch JS, Kunst CB, et al. Effect of genetic background on phenotype variability in transgenic mouse models of amyotrophic lateral sclerosis: a window of opportunity in the search for genetic modifiers. Amyotroph Lateral Scler. 2011;12(2):79&#x2013;86. doi: 10.3109/17482968.2010.550626.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.550626</ArticleId><ArticleId IdType="pubmed">21241159</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau E, Di Polo A, Vande Velde C, Robitaille R (2020) Sex-specific differences in motor-unit remodeling in a mouse model of ALS. eNeuro 7(1):ENEURO.0388-19.2020. 10.1523/ENEURO.0388-19.2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7044502</ArticleId><ArticleId IdType="pubmed">32033983</ArticleId></ArticleIdList></Reference><Reference><Citation>Riar AK, Burstein SR, Palomo GM, Arreguin A, Manfredi G, Germain D. Sex specific activation of the ERalpha axis of the mitochondrial UPR (UPRmt) in the G93A-SOD1 mouse model of familial ALS. Hum Mol Genet. 2017;26(7):1318&#x2013;1327. doi: 10.1093/hmg/ddx049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx049</ArticleId><ArticleId IdType="pmc">PMC6075578</ArticleId><ArticleId IdType="pubmed">28186560</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster CP, Smith EF, Shaw PJ, De Vos KJ. Protein homeostasis in amyotrophic lateral sclerosis: therapeutic opportunities? Front Mol Neurosci. 2017;10:123. doi: 10.3389/fnmol.2017.00123.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00123</ArticleId><ArticleId IdType="pmc">PMC5411428</ArticleId><ArticleId IdType="pubmed">28512398</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady OA, Meng P, Zheng Y, Mao Y, Hu F. Regulation of TDP-43 aggregation by phosphorylation and p62/SQSTM1. J Neurochem. 2011;116(2):248&#x2013;259. doi: 10.1111/j.1471-4159.2010.07098.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.07098.x</ArticleId><ArticleId IdType="pubmed">21062285</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sarraj S, King A, Troakes C, Smith B, Maekawa S, Bodi I, et al. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol. 2011;122(6):691&#x2013;702. doi: 10.1007/s00401-011-0911-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0911-2</ArticleId><ArticleId IdType="pubmed">22101323</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin S, St-Pierre J. PGC1alpha and mitochondrial metabolism&#x2013;emerging concepts and relevance in ageing and neurodegenerative disorders. J Cell Sci. 2012;125(Pt 21):4963&#x2013;4971. doi: 10.1242/jcs.113662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.113662</ArticleId><ArticleId IdType="pubmed">23277535</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang H, Ward WF. PGC-1alpha: a key regulator of energy metabolism. Adv Physiol Educ. 2006;30(4):145&#x2013;151. doi: 10.1152/advan.00052.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/advan.00052.2006</ArticleId><ArticleId IdType="pubmed">17108241</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiota M, Yokomizo A, Tada Y, Inokuchi J, Tatsugami K, Kuroiwa K, et al. Peroxisome proliferator-activated receptor gamma coactivator-1alpha interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR. Mol Endocrinol. 2010;24(1):114&#x2013;127. doi: 10.1210/me.2009-0302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/me.2009-0302</ArticleId><ArticleId IdType="pmc">PMC5428145</ArticleId><ArticleId IdType="pubmed">19884383</ArticleId></ArticleIdList></Reference><Reference><Citation>Tcherepanova I, Puigserver P, Norris JD, Spiegelman BM, McDonnell DP. Modulation of estrogen receptor-alpha transcriptional activity by the coactivator PGC-1. J Biol Chem. 2000;275(21):16302&#x2013;16308. doi: 10.1074/jbc.M001364200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M001364200</ArticleId><ArticleId IdType="pubmed">10748020</ArticleId></ArticleIdList></Reference><Reference><Citation>Eschbach J, Schwalenstocker B, Soyal SM, Bayer H, Wiesner D, Akimoto C, et al. PGC-1alpha is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis. Hum Mol Genet. 2013;22(17):3477&#x2013;3484. doi: 10.1093/hmg/ddt202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt202</ArticleId><ArticleId IdType="pubmed">23669350</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>